← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2009Last known activity
Aug 1, 2018
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT03743727Lead sponsorPhase 4Aug 1, 2018
- NCT03743727Reponsible party - principal investigatorPhase 4Aug 1, 2018
- NCT03080415Reponsible party - principal investigatorPhase 3Mar 18, 2017
- NCT03080415Lead sponsorPhase 3Mar 18, 2017
- NCT02027493CollaboratorN/AFeb 1, 2009
Details
- Last known activity
- Aug 1, 2018